Dabrafenib Cost in Canada
I cannot provide specific Canadian pricing for dabrafenib 75 mg daily because the available evidence only contains U.S. pricing data and does not include Canadian cost information 1.
Available U.S. Pricing Context
The research literature discusses dabrafenib costs in the context of combination therapy with trametinib for melanoma treatment, but specific per-milligram or monthly costs for dabrafenib monotherapy at 75 mg daily are not provided in the available evidence 2, 1, 3.
- One Canadian cost-effectiveness analysis from 2015 evaluated dabrafenib versus other treatments but used "list prices" without specifying the actual dollar amounts 1.
- The study noted that dabrafenib was assumed to have a "lower daily cost" compared to vemurafenib, but exact pricing figures were not disclosed 1.
Important Clinical Context
Dabrafenib 75 mg daily represents a dose-reduced regimen, as the standard approved dosing for BRAF V600-mutated melanoma is 150 mg twice daily (300 mg total daily dose) 2, 4.
- The 75 mg daily dose would typically be used in patients requiring dose reduction due to adverse events or tolerability issues 4.
- Cost would theoretically be approximately one-quarter of the standard full-dose regimen cost.
Obtaining Accurate Canadian Pricing
Contact the manufacturer (Novartis) directly or consult provincial drug formularies for current Canadian pricing, as medication costs vary significantly by:
- Provincial drug benefit programs 1
- Private insurance formulary placement
- Patient assistance programs available through the manufacturer 5
- Pharmacy dispensing fees and markups specific to each province
The 2015 Canadian analysis used a 5% annual discount rate and Canadian healthcare system perspective, but the actual acquisition costs were not published in the publicly available literature 1.